We recently released our second quarter 2025 earnings, along with important corporate updates regarding the ongoing launch and rollout of VLN ® products. VLN ® cigarettes are the first and only ...
New platform empowers commercial and public-sector treasury teams to turn account balances into a revenue engine ...
22nd Century Group, Inc. (XXII) is one of the most interesting stocks in biotechnology right now. The company, which bills itself as a biotechnology company and is based in New York, has developed a ...
22nd Century Technologies has acquired the federal contracting division of U.K.-headquartered BT Group in a move to bring more telecommunications and networking experience into the larger managed ...
Detailed price information for 22nd Century Group Inc (XXII-Q) from The Globe and Mail including charting and trades.
Meet 22nd Century Group, the biotech co. driven by the mission to reduce the harm caused by smoking.
Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results